Sector movers: AstraZeneca, Shire lift pharma stocks on upbeat guidance
14th Jan 2014 15:22
Decent gains from AstraZeneca and Shire gave the pharmaceuticals sector a boost on Tuesday as both firms gave confident outlooks. At the JP Morgan Healthcare Conference in San Francisco, AstraZeneca Chief Executive Pascal Soriot said he expects the company to return to growth sooner than analysts c
Read moreRegenersis CFO tops up stake as results impress
24th Sep 2013 16:44
Jog Dhody, the Chief Financial Officer of Regenersis, on Tuesday acquired 39,000 ordinary shares in the outsourcing partner on the same day it posted "a strong financial performance and good growth" for the year ended June 30th. Dhody bought the shares a price of 255p per share, spending a total o
Read moreFutura Medical losses shrink as launch climax approaches - UPDATE
12th Sep 2013 10:27
Losses contracted slightly at condom developer Futura Medical in the first half-year, as it continued to massage the costs of bringing its lead product towards the climax of market launch in 2014. Losses before tax shrank from £1.08m to £1.03m, as a net cash outflow of £0.7m saw the AIM company ho
Read moreFutura Medical signs marketing and distribution deal with Church & Dwight
2nd Apr 2013 13:26
Futura Medical, a pharmaceutical group that develops innovative products for consumer healthcare, has signed an agreement with Church & Dwight Co., for the marketing and distribution of CSD500, Futura's new condom product under the Trojan brand. Under the terms of the agreement, Church & Dwight wi
Read moreChairman and CEO of Mediterranean Oil & Gas stock up
9th Jan 2013 16:15
Both the Chairman and Chief Executive of Mediterranean Oil & Gas (MOG) increased their holdings in the company on Tuesday, one day after it said it was 'pleased' with its production activities in Italy last year, setting the stage for a strong 2013. CEO William Higgs purchased 200,000 shares at 10
Read moreFuture Medical places shares at tiny discount
14th Sep 2012 08:46
Futura Medical, best known for its condom products which help maintain a firmer erection during sexual intercourse, is to raise funds through a placing of shares at a tiny discount to the prevailing share price. The company intends to raise £2.08m, gross, through the placing of 3.65m shares at 57p
Read moreFall-out between Reckitt Benckiser and Futura over CSD 500
28th Aug 2012 11:24
The British firm that says it has created an erection sustaining condom has fallen out with its marketing partner, Reckitt Benckiser, forcing it to go ahead with production on its own. Futura Medical says it was unable to find: "common ground acceptable to both parties in respect of their continued
Read moreFutura expects lower loss
14th Feb 2011 14:28
AIM-quoted erectile dysfunction treatments developer Futura Medical says that its loss fell in 2010. Revenues generated from commercial payments from partners increased from £50,000 to £125,000. The loss fell from £1.51m to £1.32m. There is still £1m in the bank. The CSD500 condom still requir
Read moreTakeover targets named
29th Jan 2011 14:04
Hold on tight, a wave of patent expiries and generic competition could spark another round of consolidation in the pharma and medical devices sector this year. Billions of dollars have been spent on takeovers or pumped into new issues in recent months as confidence in the recovery grows and cash-ri
Read moreFutura hit by more delays to CSD500
18th Jan 2011 16:37
Erectile dysfunction treatments developer Futura Medical says that there will be further delays in the CSD500 condom getting its CE mark but management believes that the regulator's queries can be addressed in a relatively short period of time. The CSD500 condom helps men to maintain a firm erect
Read moreSmall caps round-up: Forte Energy, Futura Medical, Hightex...
23rd Dec 2010 11:37
Forte Energy has completed a 7,000m drilling program at its A238 uranium anomaly in the north of its leases in Mauritania and a 1,500m diamond drilling program should be completed next month. "These initial results are from the first pass shallow drilling along strike, and confirm the presence of
Read moreLondon close: US spurs Footsie recovery
8th Sep 2010 16:36
Footsie put its weak start behind it to close with good gains, helped by buoyant trading on Wall Street. US shares recovered from losses yesterday that snapped a recent winning streak. Among the risers here was ARM Holdings. UBS has issued a downbeat assessment of the European semiconductor mark
Read moreLondon afternoon: ARM in line for Samsung boost
8th Sep 2010 14:28
Footsie emerged from the lunch-time session nursing a small gain, with the majority of the blue-chip index's constituents in positive territory. Chief among them was chip designer ARM Holdings. UBS has issued a downbeat assessment of the European semiconductor market but it has made an exception o
Read moreSmall caps round-up: Ark Therapeutics, Alkane Energy, CPL
8th Sep 2010 12:59
Speciality drug developer AGI Therapeutics posted narrower losses in the six months to June 30 and said it was on the look-out for 'external opportunities.' The company, which is developing treatments for gastrointestinal disorders and multiple sclerosis, saw pre-tax losses narrow to $3.1m from $9.
Read moreCORRECT: =3rd UPDATE: Reckitt Benckiser In GBP2.54B SSL Deal
21st Jul 2010 11:05
("=3rd UPDATE: Reckitt Benckiser Agrees GBP2.54B Offer For SSL," at 0911 GMT, misstated Reckitt's total workforce in the last paragraph. The correct version follows:) (Adds detail and analyst's comment.) By Jason Douglas and Michael Carolan Of DOW JONES NEWSWIRES LONDON (Dow Jones)-
Read more